image
Healthcare - Biotechnology - NASDAQ - US
$ 1.1201
-3.44 %
$ 2.29 M
Market Cap
-0.06
P/E
BALANCE SHEET
7.98 M ASSETS
14.89%
1.62 M LIABILITIES
75.98%
6.36 M EQUITY
5.53%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Dermata Therapeutics, Inc.
image
Current Assets 7.98 M
Cash & Short-Term Investments 7.44 M
Receivables 8.36 K
Other Current Assets 532 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 1.62 M
Accounts Payable 866 K
Short-Term Debt 0
Other Current Liabilities 758 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 7.4 6.2 10.8 0.5 2.0
Short Term Investments 0 0 0 0 0
Receivables 8.36 K 12.6 K 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 0.5 0.7 0.8 75.1 K 73.7 K
Total Current Assets 8.0 6.9 11.6 0.6 2.1
PP&E 0 0 0 0 322
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 0 0 55.7 K 0 0
Other Assets 0 703.2 55.7 K 0 0
Total Assets 8.0 6.9 11.6 0.6 2.1
LIABILITIES
Accounts Payable 0.9 0.5 0.5 0.1 0.3
Short Term Debt 0 0 0 3.5 0.7
Other Current Liabilities 0.8 0.4 1.0 0.1 0.7
Total Current Liabilities 1.6 0.9 1.5 3.8 1.7
Long Term Debt 0 0 0 0 0.6
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 0 0
Total Liabilities 1.6 0.9 1.5 3.8 2.3
EQUITY
Common Stock 393 1.23 K 833 2.4 2.4
Retained Earnings (53.4) (45.6) (36.0) (28.1) (24.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 (53.0) (49.5)
Total Equity 6.4 6.0 10.1 (28.1) (24.8)
Total Liabilities and Equity 8.0 6.9 11.6 3.8 2.3
SHARES OUTSTANDING
Common Shares Outstanding 0.2 0.7 0.5 0.5 0.5